Oncostatin M induces RIG‐I and MDA5 expression and enhances the double‐stranded RNA response in fibroblasts

Authors:

Abstract
Interleukin (IL)‐6‐type cytokines have no direct antiviral activity; nevertheless, they display immune‐modulatory functions. Oncostatin M (OSM), a member of theIL‐6 family, has recently been shown to induce a distinct number of classical interferon stimulated genes (ISG). Most of them are involved in antigen processing and presentation. However, induction of retinoic acid‐inducible gene (RIG)‐I‐like receptors (RLR) has not been investigated. Here we report thatOSMhas the capability to induce the expression of theDExD/H‐BoxRNAhelicasesRIG‐I and melanoma differentiation antigen 5 (MDA5) as well as of the transcription factors interferon regulatory factor (IRF)1,IRF7 andIRF9 in primary fibroblasts. Induction of the helicases depends on tyrosine as well as serine phosphorylation ofSTAT1. Moreover, we could show that theOSM‐inducedSTAT1 phosphorylation is predominantly counter‐regulated by a strongSTAT3‐dependentSOCS3 induction, asStat3as well asSocs3knock‐down results in an enhanced and prolonged helicase andIRFexpression. Other factors involved in regulation ofSTAT1 orIRF1 activity, like protein tyrosine phosphatase, non‐receptor type 2 (PTPN2), promyelocytic leukaemia protein (PML) or small ubiquitin‐related modifier 1 (SUMO1), play a minor role inOSM‐mediated induction ofRLR. Remarkably,OSMand interferon‐γ (IFN‐γ) synergize to mediate transcription ofRLRand pre‐treatment of fibroblasts withOSMfosters the type I interferon production in response to a subsequent encounter with double‐strandedRNA. Together, these findings suggest that theOSM‐inducedJAK/STAT1 signalling is implicated in virus protection of non‐professional immune cells and may cooperate with interferons to enhanceRLRexpression in these cells.
Funding Information
  • Deutsche Forschungsgemeinschaft (SFB 487, SFB 688)

This publication has 70 references indexed in Scilit: